| Literature DB >> 29661183 |
Alison Hammond1, Yeliz Prior2, Sarah Tyson3.
Abstract
BACKGROUND: Although the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is widely used in the UK, no British English version is available. The aim of this study was to linguistically validate the DASH into British English and then test the reliability and validity of the British English DASH, (including the Work and Sport/Music DASH) and QuickDASH, in people with rheumatoid arthritis (RA).Entities:
Keywords: Patient reported outcomes; Rehabilitation; Rheumatoid arthritis; Upper limb assessment
Mesh:
Year: 2018 PMID: 29661183 PMCID: PMC5902839 DOI: 10.1186/s12891-018-2032-8
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
DASH study participant characteristics (n = 340)
| Participant Characteristics | Cognitive debriefing | Psychometric testing: |
|---|---|---|
| Age:(Mean (SD) | 63.42 (12.04) | 61.96 (12.09) |
| Gender (M:F) | 5:26 | 89:251 |
| Condition duration (years) (Mean (SD): | 15.71 (12.61) | 14.44 (11.73) |
| Marital status: n (%) | ||
| Married/living with partner | 23 (74%) | 241 (71%) |
| Living status: n (%) | ||
| Family/significant other | 24 (77%) | 245 (72%) |
| Children living at home | 4 (13%) | 36 (11%) |
| Employment status | ||
| Paid employment | 3 (10%) | 108 (32%) |
| Retired | 22 (71%) | 204 (60%) |
| Other | 6 (19%) | 28 (8%) |
| Education level (ISCED) | ||
| Secondary education only | 19 (61%) | 182 (54%) |
| Current medication | ||
| Not on DMARDs | 2 (6%) | 34 (10%) |
| Monotherapy | 10 (32%) | 91 (27%) |
| Combination therapy | 10 (32%) | 190 (56%) |
| Biologic drugs | 9 (29%) | 25 (7%) |
Fig. 1British English DASH in RA: Recruitment & Study Progress Flow Diagram. Key: DASH = Disabilities in the Arm, Shoulder and Hand questionnaire; EDAQ = Evaluation of Daily Activity Questionnaire; RA = Rheumatoid Arthritis study; NHS = National Health Service
Descriptive data for health status measures (n = 340)
| Health status measures | Test 1 ( | Test 2 ( |
|---|---|---|
| DASH (range 0–100) | 35.34 (18.33–56.35) | 36.67 (16.95–55.00) |
| QuickDASH (range 0–100) | 34.09 (15.91–50.0) | 36.36 (18.18–56.81) |
| WORKDASH (0–100) | 25 (6.25–43.75) | 25 (0–39.06) |
| SPAMDASH (range 0–100) | 25 (12.50–59.38) | 31.25 (18.75–75.0) |
| Test 1 only: | ||
| Disease activity level NRS (range 0–10) | 4 (2–6) | |
| Pain when moving NRS (range 0–10) | 5 (2–7) | |
| SF36v2 Bodily Pain (range 0–100) | 42.24 (34.18–47.48) | |
| Hand pain on activity NRS (range 0–10) | 4 (2–7) | |
| Fatigue NRS (0–10) | 6 (4–8) | |
| SF36v2 Vitality (range 0–100) | 43.69 (34.77–49.63) | |
| HAQ20 (0–60) | 13 (4–23) | |
| Hand HAQ (range 0–21) | 5 (1.75–10) | |
| MAPHAND (range 0–54) | 17 (8.25–27) | |
| SF36v2 Physical Function (range 0–100) | 36.49 (26.93–46.06) | |
| RAQOL (range 0–30) | 10.50 (4–19) | |
Concurrent validity of the DASH, WORKDASH and SPAMDASH with health status, activity limitation and quality of life measures
| Disease activity NRS | Pain on movement NRS | Fatigue NRS | Hand pain on activity NRS | HAQ20 | Hand HAQ | MAPHAND | RAQOL | SF36v2 Physical Function | SF36v2 | SF36v2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DASH ( | 0.61** | 0.70** | 0.64** | 0.75** | 0.91** | 0.88** | 0.93** | 0.80** | -0.85** | -0.74** | −0.63** |
| QuickDASH | 0.61** | 0.70** | 0.65** | 0.76** | 0.87** | 0.84** | 0.91** | 0.79** | −0.82** | − 0.73** | −0.62** |
| WORKDASH | 0.54** | 0.62** | 0.62** | 0.69** | 0.80** | 0.74** | 0.74** | 0.74** | −0.71** | −0.71** | − 0.53** |
| SPAMDASH | 0.52** | 0.55** | 0.48** | 0.57** | 0.69** | 0.60** | 0.71** | 0.78** | −0.74** | − 0.71** | −0.61** |
Key: Spearman’s correlations; ** p < 0.001; NRS numeric rating scale
Discriminant validity: DASH (n = 327), QuickDASH (n = 334), WORKDASH (n = 157) and SPAMDASH (n = 57) median (IQR) scores and differences between perceived disease activity groups
| Low disease activity (0–3) | Moderate disease activity (4–6) | High disease activity (7–10) | Chi-square | df | p | |
|---|---|---|---|---|---|---|
| DASH | 19.58 (9.58–36.32) | 42.81 (27.29–58.33) | 57.50 (43.33–72.50) | 399.40 | 332 | 0.007 |
| QuickDASH | 15.91 (6.82–36.36) | 40.91 (25.00–52.27) | 56.82 (39.77–65.91) | 214.00 | 102 | 0.000 |
| WORKDASH | 12.50 (0–29.69) | 28.13 (18.75–50.0) | 50.0 (31.25–68.75) | 71.37 | 28 | 0.000 |
| SPAMDASH | 25 (0–37.5) | 56.25 (31.25–87.50) | 100 (75.00–100) | 50.02 | 28 | 0.006 |
Internal consistency and test-retest reliability of the DASH, QuickDASH, WORKDASH and SPAMDASH (for those reporting “the same” at Test 2)
| Cronbach’s alpha | n for test-retest | Test 1 score (median, IQR) | Test 2 score (median, IQR) | Spearman’s Correlation (rs) | ICC(2,1) (95% CI) | |
|---|---|---|---|---|---|---|
| DASH | 0.98 | 170 | 30.83 (15.83–55.00) | 30.00 (12.50–53.33) | 0.95** | 0.97 (0.96,0.98) |
| QuickDASH | 0.94 | 180 | 29.55 (13.63–47.73) | 30.00 (13.63–53.41) | 0.93** | 0.95 (0.94,0.96) |
| WORKDASH | 0.94 | 53 | 25.00 (6.25–37.50) | 25.00 (0–37.50) | 0.74** | – |
| SPAMDASH | 0.97 | 19 | 25.00 (12.50–48.44) | 25.00 (18.75–75.00) | 0.92** | – |
Key: Spearman’s correlations; ** p < 0.001